S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

PRPH ProPhase Labs Inc

5.42

0.11 (2.07%)

04 May 2024 - Closed

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more ProPhase Labs Charts.

ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more ProPhase Labs Charts.

Prophase Labs, Inc. News

PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
Thursday 2 May 2024 (2 days ago) • GlobeNewswire Inc.

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.

ProPhase Labs Unveils Project ZenQ-AI
Tuesday 16 April 2024 (3 weeks ago) • GlobeNewswire Inc.

ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
Wednesday 10 April 2024 (3 weeks ago) • GlobeNewswire Inc.

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.

ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
Friday 15 March 2024 (2 months ago) • GlobeNewswire Inc.

PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
Saturday 9 March 2024 (2 months ago) • GlobeNewswire Inc.

ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART
Wednesday 21 February 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
Thursday 15 February 2024 (3 months ago) • GlobeNewswire Inc.

ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
Wednesday 31 January 2024 (3 months ago) • GlobeNewswire Inc.

Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
Wednesday 24 January 2024 (3 months ago) • GlobeNewswire Inc.

More Prophase Labs, Inc. News Articles

Commonwealth Bank Of Aus...

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions